<SEC-DOCUMENT>0001628280-24-045012.txt : 20241104
<SEC-HEADER>0001628280-24-045012.hdr.sgml : 20241104
<ACCEPTANCE-DATETIME>20241104162004
ACCESSION NUMBER:		0001628280-24-045012
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20241030
ITEM INFORMATION:		Termination of a Material Definitive Agreement
ITEM INFORMATION:		Results of Operations and Financial Condition
FILED AS OF DATE:		20241104
DATE AS OF CHANGE:		20241104

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MEDIFAST INC
		CENTRAL INDEX KEY:			0000910329
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS [2090]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				133714405
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31573
		FILM NUMBER:		241423863

	BUSINESS ADDRESS:	
		STREET 1:		11445 CRONHILL DRIVE
		CITY:			OWINGS MILLS
		STATE:			MD
		ZIP:			21117
		BUSINESS PHONE:		7327640619

	MAIL ADDRESS:	
		STREET 1:		11445 CRONHILL DRIVE
		CITY:			OWINGS MILLS
		STATE:			MD
		ZIP:			21117

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHRITE INC
		DATE OF NAME CHANGE:	19951120

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XX
		DATE OF NAME CHANGE:	19950619

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	00
		DATE OF NAME CHANGE:	19950619
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>med-20241030.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:ff861412-6b9b-443a-a223-d13ffb79620b,g:78c4c6f0-d32f-420b-85de-ae2630e47498,d:49e2db9bce7e403dadd17e7bec3b2c85-->
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:exch="http://xbrl.sec.gov/exch/2023" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>med-20241030</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-21">0000910329</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-22">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="med-20241030.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-04</xbrli:startDate><xbrli:endDate>2024-11-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000910329</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-11-04</xbrli:startDate><xbrli:endDate>2024-11-04</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i49e2db9bce7e403dadd17e7bec3b2c85_1"></div><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">_____________________________________</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM&#160;<ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Securities Exchange Act of 1934</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported):&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">October 30, 2024</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">MEDIFAST, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-31573</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">13-3714405</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(State or other</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">jurisdiction of incorporation)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Commission</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">File Number)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(I.R.S. Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identification No.)</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">100 International Drive</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Baltimore</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">Maryland</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">21202</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of Principal Executive Offices) (Zip Code)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant's telephone number, including area code:&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">410</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">581-8042</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">N/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former Name or Former Address, if Changed Since Last Report)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:40.627%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.629%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:5.62pt;padding-right:5.62pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center;text-indent:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-13">Common Stock, par value $0.001 per share</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-14">MED</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-2" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-15">New York Stock Exchange</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;General Instruction A.2. below):</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:4.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:93.199%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-17">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-18">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-19">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR&#160;&#167;240.12b-2).</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:96.122%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.578%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:324pt;text-align:right;text-indent:-324pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-20">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt"><span><br/></span></div><div id="i49e2db9bce7e403dadd17e7bec3b2c85_7"></div><div style="padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.02. &#160;&#160;&#160;&#160;Termination of a Material Definitive Agreement.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On October 30, 2024, Medifast, Inc. (the "Company") terminated its Credit Agreement, dated as of April 13, 2021, among the Company, certain of its subsidiaries party thereto, the lenders party thereto, and with Citibank, N.A., as administrative agent, as amended on May 31, 2022 (the &#8220;Credit Agreement&#8221;). The Credit Agreement provided, among other things, for a secured revolving credit facility in the principal amount of up to $225 million with a $20 million letter of credit sublimit.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company terminated the Credit Agreement in accordance with its terms. As of the date of termination, the Company did not have any borrowings under the Credit Agreement inclusive of the credit facility and letter of credit sublimit, and the Company was in compliance with all covenants. In addition, the Company did not incur any premium or early penalties in connection with the termination of the Credit Agreement.</span></div><div id="i49e2db9bce7e403dadd17e7bec3b2c85_138"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.02.&#160;&#160;&#160;&#160;Results of Operations and Financial Condition.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On November 4, 2024, the Company issued a press release announcing its earnings for the third quarter ended September 30, 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">A copy of the Press Release is being furnished as Exhibit 99.1 attached hereto and is incorporated by reference herein. This information is being furnished in this report and shall not be deemed to be "filed" for any purpose, including for the purpose of Section 18 of the Securities and Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1993, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.</span></div><div id="i49e2db9bce7e403dadd17e7bec3b2c85_13"></div><div style="-sec-extract:summary;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01.&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:83.404%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Exhibits.</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="medfinalearningsrelease110.htm">Medifast Announces Third Quarter 2024 Financial Results</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL Document)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i49e2db9bce7e403dadd17e7bec3b2c85_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Signature</span></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.145%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.847%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.708%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MEDIFAST, INC.</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ James P. Maloney</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">James P. Maloney</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: November 4, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>medfinalearningsrelease110.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="id8a729a8e62144c9996ac496d7eeace7_36"></div><div style="min-height:72pt;width:100%"><div><img alt="imagea.jpg" src="imagea.jpg" style="height:69px;margin-bottom:5pt;vertical-align:text-bottom;width:197px"></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:16pt;font-weight:700;line-height:125%">Medifast Announces Third Quarter 2024 Financial Results </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">November 4, 2024</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">BALTIMORE &#8211; (</font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">BUSINESS WIRE</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">)--</font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Medifast</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> (NYSE&#58; MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, </font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OPTA</font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA&#174;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">, today reported results for the third quarter ended September 30, 2024.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Third Quarter 2024</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:14.15pt">Revenue of $140.2 million, with revenue per active earning coach of $4,672</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:14.15pt">Independent active earning</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%"> OPTA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA coaches of 30,000</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:14.15pt">Net income of $1.1 million (non-GAAP adjusted net income of $3.9 million)</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:14.15pt">Income per diluted share of $0.10</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> (non-GAAP adjusted earnings per share (&#34;EPS&#34;) of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">$0.35</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">)</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%;padding-left:14.15pt">Cash, Cash Equivalents, and Investment Securities of $170.0 million with no debt</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8220;Medical innovation has transformed the weight loss industry, so at Medifast we&#8217;re creating a health and wellness business of the future by meeting the unique needs of customers regardless of their approach to their health goals,&#8221; said Dan Chard, Chairman &#38; CEO.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#8220;We offer comprehensive support for medication users including access to clinicians through LifeMD, as well as programs and products to help maintain muscle and minimize side effects. We&#8217;re developing customized solutions for those looking to maintain their weight and build a healthier lifestyle beyond medication usage. Importantly, our clinically-studied coach-led program remains a powerful solution for those not using medications at all, combining the community support, a habit-based approach and nutritional products that are a hallmark of all our OPTAVIA programs, having already helped over 3 million people achieve improved health.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Chard concluded, &#8220;With tailored plans, personal solutions and a focused approach to driving customer acquisition, we believe that our strategy can drive sustainable growth in the quarters and years ahead.&#8221;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Third Quarter 2024 Results</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Third quarter 2024 revenue decreased 40.6% to $140.2 million from $235.9 million for the third quarter of 2023 primarily driven by a decrease in the number of active earning </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OPTA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA coaches and lower coach productivity. The total number of active earning </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OPTA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA coaches decreased 36.3% to 30,000 compared to 47,100 for the third quarter of 2023. The average revenue per active earning </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OPTA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA coach was $4,672, compared to $5,008 for the third quarter last year, primarily driven by continued pressure on customer acquisition.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Gross profit decreased 40.4% to $105.7 million from $177.4 million for the third quarter of 2023. The decrease in gross profi</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">t was primarily </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">due to lower revenue. Gross profit margin was 75.4% compared to 75.2% in the third quarter of 2023.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Selling, general, and administrative expenses (&#8220;SG&#38;A&#8221;) decreased 31.8% to $103.6 million compared to $151.9 million for the third quarter of 2023. </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">decrease</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> in SG&#38;A was </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">primarily due to a $38.2 million decrease in </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OPTA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA coach compensation on fewer active earning coaches and lower volumes and $5.0 million of reduced costs for coach-related events, including convention. As a percentage of revenue, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><img alt="imagea.jpg" src="imagea.jpg" style="height:69px;margin-bottom:5pt;vertical-align:text-bottom;width:197px"></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">SG&#38;A increased 950</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> basis points </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">year-over-year to 73.9% of revenue, as compared to 64.4% for the third quarter of 2023. The increase in SG&#38;A as a percentage of revenue was primarily due to approximately 590 basis points of costs for Company-led customer acquisition initiatives and 340 basis points attributable to the loss of leverage on fixed costs due to lower sales volumes. Non</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">-GAAP adjusted </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">SG&#38;A, which excludes the final $1.7 million of expenses related to the company&#8217;s overall $10 million collaboration with LifeMD, decreased</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> 32.9% to </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">$101.9 million</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> and </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">non-GAAP adjusted SG&#38;A as a percentage of revenue increased 830 basis points year-over-year to 72.7%.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The company's income from operations for the period was $2.1 million, a decrease of </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">91.7%</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> from income from operations of $25.5 million in the prior year comparable period. As a percentage of revenue, income from operations was 1.5% for the third quarter of 2024 compared to 10.8% in the prior-year period. </font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Non-GAAP adjusted income from operations </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">decreased</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> 85.3% to </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">$3.8</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> million. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Non-GAAP adjusted income from operations as a percentage of revenue was 2.7%, a decrease of 810 basis points from the year-ago period.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The effective tax rate was 28.5% for the third quarter of 2024 compared to 12.9% in the prior-year period. The increase in the effective tax rate for the three months ended September 30, 2024 was primaril</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">y driven by a decrease in the tax benefit for donations of inventory compared to 2023. The non-GAAP effective tax rate was </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">26.0%</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> as compared to </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">12.9%</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> in the prior year period.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">In the third quarter of 2024, the company's net income was $1.1 million, or $0.10 per diluted share, based on approximately 11.0</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> million shares </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">of common stock outstanding. In the third quarter of 2023, net income was $23.1 million, or $2.12 per diluted share, based on approximately 10.9</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> million shares</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> of common stock outstanding.</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> In the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">third</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> quarter </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">2024</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">, non-GAAP adjusted net income was </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">$3.9</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> million, or </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">$0.35</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> per diluted share.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Capital Allocation and Balance Sheet</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The company&#8217;s balance sheet remains strong with $170.0 million in cash, cash equivalents and investment securities and no debt as of September 30, 2024, compared to $150.0 million in cash, cash equivalents and investment securities and no debt at December 31, 2023. As of September 30, 2024, the company maintained a $225 million credit facility. Given the company&#8217;s healthy cash position, which is projected to be maintained through the expiration of the credit facility, the company cancelled its credit agreement, effective October 30, 2024. This action was made as part of the Fuel for the Future initiative, as the company incurred approximately $50 thousand of cash expenses related to the termination and expects to achieve annual savings of approximately $500 thousand in commitment fees. Unamortized debt issuance costs totaling $419 thousand will be expensed in the fourth quarter of 2024. The credit agreement termination was done in accordance with its terms. As of the date of termination, the company did not have any borrowings under the credit agreement, and the company was in compliance with all covenants. In addition, the company did not incur any premium or early penalties in connection with the termination.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:112%">Outlook</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The company expects fourth quarter 2024 revenue to be in the range of $100 million to $120 million and fourth quarter 2024 diluted loss per share to be in the range of $0.10 to $0.65. The EPS range excludes </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><img alt="imagea.jpg" src="imagea.jpg" style="height:69px;margin-bottom:5pt;vertical-align:text-bottom;width:197px"></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">any gains or losses from changes in the market price of the company&#8217;s LifeMD common stock investment.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Conference Call Information</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The conference call is scheduled for today, Monday, November 4, 2024 at 4&#58;30 p.m. ET. The call will be broadcast live over the Internet, hosted on the Investor Relations section of Medifast&#8217;s website at </font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">www.MedifastInc.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> or directly at </font><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">https&#58;&#47;&#47;viavid.webcasts.com&#47;starthere.jsp&#63;ei&#61;1691825&#38;tp_key&#61;981ddaa9cf</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%"> and will be archived online and available through February 4, 2025. In addition, listeners may dial 201-389-0879 to join via telephone.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">A telephonic playback will be available from 7&#58;30 p.m. ET, November 4, 2024, through November 11, 2024. Participants can dial 412-317-6671 and enter passcode 13749320 to hear the playback.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%;text-decoration:underline">About Medifast</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:7.15pt;font-weight:700;line-height:125%;position:relative;top:-3.85pt;vertical-align:baseline">&#174;</font><font style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">&#58;</font><font style="background-color:#ffffff;color:#504640;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%;text-decoration:underline"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Medifast (NYSE&#58; MED) is the health and wellness company known for its habit-based and coach-guided lifestyle solution </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OPTA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA&#174;, which provides people with a simple yet comprehensive approach to address obesity and support a healthy lifestyle. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OPTA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA's holistic solution includes lifestyle plans with clinically proven health benefits, scientifically developed products, and a framework for habit creation &#8211; all reinforced by independent coach support for customers on their weight loss journeys. Through its collaboration with national virtual primary care provider LifeMD&#174; (Nasdaq&#58; LFMD) and its affiliated medical group, the holistic solution now includes access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature&#8482;. Visit the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OPTA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA and Medifast websites for more information and follow &#64;Medifast on X and LinkedIn.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">MED-F</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Forward Looking Statements</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Please Note&#58; This release contains &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally can be identified by use of phrases or terminology such as &#8220;intend,&#8221; &#8220;anticipate,&#8221; &#8220;expect&#8221; or other similar words or the negative of such terminology. Similarly, descriptions of Medifast&#8217;s objectives, strategies, plans, goals, outlook or targets contained herein are also considered forward-looking statements. These statements are based on the current expectations of the management of Medifast and are subject to certain events, risks, uncertainties and other factors. Some of these factors include, among others, Medifast's inability to maintain and grow the network of independent </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OPTA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA Coaches&#59; Industry competition and new weight loss products, including weight loss medications, or services&#59; Medifast&#8217;s health or advertising related claims by </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OPTA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA customers&#59; Medifast's inability to continue to develop new products&#59; effectiveness of Medifast's advertising and marketing programs, including use of social media by </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">OPTA</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">VIA Coaches&#59; the departure of one or more key personnel&#59; Medifast's inability to protect against online security risks and cyberattacks&#59; risks associated with Medifast's direct-to-consumer business model&#59; disruptions in Medifast's supply chain&#59; product liability claims&#59; Medifast's planned growth into domestic markets including through its collaboration with LifeMD, Inc.&#59; adverse publicity associated with Medifast's products&#59; the impact of existing and future laws and regulations on Medifast&#8217;s business&#59; fluctuations of Medifast's common stock market price&#59; increases in litigation&#59; actions of activist investors&#59; the consequences of other geopolitical events, overall economic and market conditions and the resulting impact on consumer sentiment and spending patterns&#59; and Medifast's </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><img alt="imagea.jpg" src="imagea.jpg" style="height:69px;margin-bottom:5pt;vertical-align:text-bottom;width:197px"></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">ability to prevent or detect a failure of internal control over financial reporting. Although Medifast believes that the expectations, statements and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, and other filings filed with the United States Securities and Exchange Commission, including its quarterly reports on Form 10-Q and current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Investor Contact&#58;</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Medifast, Inc.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Steven Zenker</font></div><div><font style="color:#0563c1;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">InvestorRelations&#64;medifastinc.com</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">(443) 379-5256</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><img alt="imagea.jpg" src="imagea.jpg" style="height:69px;margin-bottom:5pt;vertical-align:text-bottom;width:197px"></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">MEDIFAST, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(U.S. dollars in thousands, except per share amounts &#38; dividend data)</font></div><div style="text-align:center"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.439%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Three months ended September 30,</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Nine months ended September 30,</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2024</font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2023</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2024</font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2023</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Revenue</font></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">140,163</font></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$ 235,86</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$ 483,46</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$ 881,03</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cost of sales</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">34,489</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">58,492</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">127,056</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">246,558</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Gross profit</font></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">105,674</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">177,377</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">356,404</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">634,481</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Selling, general, and administrative</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">103,568</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">151,868</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">354,235</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">516,755</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Income from operations</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2,106</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">25,509</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2,169</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">117,726</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other (expense) income</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Interest income</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,333</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,033</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3,851</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,314</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other (expense) income</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(1,861)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">7</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(3,508)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(45)</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">(528)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,040</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">343</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,269</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Income before provision for income taxes</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">1,578</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">26,549</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">2,512</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">118,995</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Provision for income taxes</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">449</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">3,418</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">1,222</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">25,615</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Net income</font></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">1129</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">23131</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">1290</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">93380</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Earnings per share - basic</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.10</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.12</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.12</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8.58</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Earnings per share - diluted</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.10</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">2.12</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">0.12</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">8.55</font></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Weighted average shares outstanding</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Basic</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">10,937</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">10,892</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">10,928</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">10,881</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Diluted</font></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">10,971</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">10,933</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">10,959</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">10,925</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash dividends declared per share</font></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$ </font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">1.65&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">$ </font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">4.95&#160;</font></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><img alt="imagea.jpg" src="imagea.jpg" style="height:69px;margin-bottom:5pt;vertical-align:text-bottom;width:197px"></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDIFAST, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(U.S. dollars in thousands, except par value)</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.780%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.109%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.213%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">September 30, 202</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31, 202</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">ASSETS</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Current Assets</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Cash and cash equivalents</font></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">115,307&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">94,440&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Inventories, net</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">40,095</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">54,591</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Investments</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">54,648</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">55,601</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Income taxes, prepaid</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">8,229</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">8,727</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Prepaid expenses and other current assets</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6,696</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">10,670</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Total current assets</font></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">224,975</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">224,029</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Property, plant and equipment - net of accumulated depreciation</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">39,003</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">51,467</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Right-of-use assets</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">12,290</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">15,645</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Other assets</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">10,967</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">14,650</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Deferred tax assets, net</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">4,002</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">4,117</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">TOTAL ASSETS</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">$ 291,23</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">309,908.00</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">LIABILITIES AND STOCKHOLDERS' EQUITY</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Current Liabilities</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accounts payable and accrued expenses</font></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">66,270&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">$</font></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">86,415&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Current lease obligations</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">6,106</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">5,885</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Total current liabilities</font></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">72,376</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">92,300</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Lease obligations, net of current lease obligations</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">11,519</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">16,127</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Total liabilities</font></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">83,895</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">108,427</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Stockholders' Equity</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Common stock, par value $0.001 per share&#58; 20,000 shares authorized&#59;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">10,937 and 10,896 issued and outstanding</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">at September 30, 2024 and December 31, 2023, respectively</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">11</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">11</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Additional paid-in capital</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">31,005</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">26,573</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Accumulated other comprehensive income</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">349</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">248</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">Retained earnings</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">175,977</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:114%">174,649</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">Total stockholders' equity</font></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">207,342</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">201,481</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:114%">TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY</font></div></td><td style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">$</font></td><td style="border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">291,237</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</font></td><td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">$</font></td><td style="border-bottom:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:114%">309,908</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:114%">&#160;</font></td><td style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><img alt="imagea.jpg" src="imagea.jpg" style="height:69px;margin-bottom:5pt;vertical-align:text-bottom;width:197px"></div></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Non-GAAP Financial Measures</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">In an effort to provide investors with additional information regarding results, the company discloses various non-GAAP financial measures in the quarterly earnings press release and other public disclosures. The following GAAP financial measures have been presented on an as adjusted basis&#58; cost of sales, gross profit, SG&#38;A expenses, income from operations, other income (expense), provision for income taxes, net income, effective tax rate, and diluted earnings per share. Each of these non-GAAP financial measures excludes the impact of certain amounts as further identified below that the company believes are not indicative of its core ongoing operational performance. A reconciliation of each of these non-GAAP financial measures to its most comparable GAAP financial measure is included below. These non-GAAP financial measures are not intended to replace GAAP financial measures.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">These non-GAAP financial measures are used internally to evaluate and manage the company's operations because the company believes they provide useful supplemental information regarding the company's on-going economic performance. The company has chosen to provide this information to investors to enable them to perform more meaningful comparisons of operating results and as a means to emphasize the results of on-going operations.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:125%">The following tables reconcile the non-GAAP financial measures included in this release&#58;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDIFAST, INC. AND SUBSIDIARIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED NON-GAAP (UNAUDITED)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(U.S. dollars in thousands, except per share amounts)</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.213%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.855%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.855%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.855%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.855%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.855%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.855%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.857%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Three Months Ended September 30, 2024</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">GAAP</font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Unrealized Loss on Investment in LifeMD Common Stock</font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">LifeMD Prepaid Services Amortization</font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Non-GAAP</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cost of sales</font></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$ 34,48</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$ </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$ </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$ 34,48</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Gross profit</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">105,674</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">105,674</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Selling, general, and administrative</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">103,568</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(1,652)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">101,916</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Income from operations</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,106</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,652</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">3,758</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other income (expense)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(528)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,984</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,456</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Provision for income taxes</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">449</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">496</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">413</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,358</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Net income</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,129</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,488</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,239</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">3,856</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Diluted earnings per share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:125%;position:relative;top:-3.48pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">0.10</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">0.14</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">0.11</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">0.35</font></div></td></tr></table></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><img alt="imagea.jpg" src="imagea.jpg" style="height:69px;margin-bottom:5pt;vertical-align:text-bottom;width:197px"></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.887%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.758%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.758%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.758%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.758%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.758%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.758%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.765%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Three Months Ended September 30, 2023</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">GAAP</font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Unrealized Loss on Investment in LifeMD Common Stock</font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">LifeMD Prepaid Services Amortization</font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Non-GAAP</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cost of sales</font></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$ 58,49</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$ </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$ </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$ 58,49</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Gross profit</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">177,377</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">177,377</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Selling, general, and administrative</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">151,868</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">151,868</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Income from operations</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">25,509</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">25,509</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other income</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,040</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,040</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Provision for income taxes</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">3,418</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">3,418</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Net income</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">23,131</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">23,131</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Diluted earnings per share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:125%;position:relative;top:-3.48pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2.12</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2.12</font></div></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.116%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.122%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Nine Months Ended September 30, 2024</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">GAAP</font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Supply Chain Optimization and Restructuring of External Manufacturing Agreements</font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">OPTAVIA Convention Cancellation</font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Unrealized Loss on Investment in LifeMD Common Stock</font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">LifeMD Prepaid Services Amortization</font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Non-GAAP</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cost of sales</font></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$ 127,05</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$ (2,579</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$ </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$ </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$ </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$ 124,47</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Gross profit</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">356,404</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,579</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">358,983</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Selling, general, and administrative</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">354,235</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(12,502)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(3,000)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">(5,000)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">333,733</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Income from operations</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,169</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">15,081</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">3,000</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">5,000</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">25,250</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other income</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">343</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">3,734</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">4,077</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Provision for income taxes</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,222</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">3,770</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">750</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">934</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,250</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">7,926</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Net income</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,290</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">11,311</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,250</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">2,800</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">3,750</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">21,400</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Diluted earnings per share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:125%;position:relative;top:-3.48pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">0.12</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1.03</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">0.21</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">0.26</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">0.34</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1.95</font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><img alt="imagea.jpg" src="imagea.jpg" style="height:69px;margin-bottom:5pt;vertical-align:text-bottom;width:197px"></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.335%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.758%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.082%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.201%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.082%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.874%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.962%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Nine Months Ended September 30, 2023</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">GAAP</font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Supply Chain Optimization and Restructuring of External Manufacturing Agreements</font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">OPTAVIA Convention Cancellation</font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Unrealized Loss on Investment in LifeMD Common Stock</font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">LifeMD Prepaid Services Amortization</font></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:125%">Non-GAAP</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Cost of sales</font></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">246,558.00&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$ </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$ </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$ </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$ </font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">$ 246,55</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Gross profit</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">634,481</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">634,481</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Selling, general, and administrative</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">516,755</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">516,755</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Income from operations</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">117,726</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">117,726</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Other income</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,269</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">1,269</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Provision for income taxes</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">25,615</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">25,615</font></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Net income</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">93,380</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">93,380</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">Diluted earnings per share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:125%;position:relative;top:-3.48pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">8.55</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">&#8212;</font></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:125%">8.55</font></div></td></tr></table></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) The weighted-average diluted shares outstanding used in the calculation of these non-GAAP financial measures are the same as the weighted-average shares outstanding used in the calculation of the reported per share amounts.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>med-20241030.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:ff861412-6b9b-443a-a223-d13ffb79620b,g:78c4c6f0-d32f-420b-85de-ae2630e47498-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:med="http://www.medifast1.com/20241030" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.medifast1.com/20241030">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="med-20241030_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="med-20241030_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="med-20241030_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.medifast1.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>4
<FILENAME>med-20241030_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:ff861412-6b9b-443a-a223-d13ffb79620b,g:78c4c6f0-d32f-420b-85de-ae2630e47498-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.medifast1.com/role/Cover" xlink:type="simple" xlink:href="med-20241030.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.medifast1.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_5dd3c136-6ce5-4b90-8a8f-3ad7ecdb1c7c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_EntitiesTable_5dd3c136-6ce5-4b90-8a8f-3ad7ecdb1c7c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_1bdd7cde-ff3b-4dc8-8a7c-126ed56ebedb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityListingsExchangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_5dd3c136-6ce5-4b90-8a8f-3ad7ecdb1c7c" xlink:to="loc_dei_EntityListingsExchangeAxis_1bdd7cde-ff3b-4dc8-8a7c-126ed56ebedb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_1bdd7cde-ff3b-4dc8-8a7c-126ed56ebedb_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityListingsExchangeAxis_1bdd7cde-ff3b-4dc8-8a7c-126ed56ebedb" xlink:to="loc_dei_ExchangeDomain_1bdd7cde-ff3b-4dc8-8a7c-126ed56ebedb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_d149a6ac-a919-4d6f-baf4-79b629d9ed65" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ExchangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityListingsExchangeAxis_1bdd7cde-ff3b-4dc8-8a7c-126ed56ebedb" xlink:to="loc_dei_ExchangeDomain_d149a6ac-a919-4d6f-baf4-79b629d9ed65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS_86ee216d-6142-4a59-a581-fcf4f4ba7574" xlink:href="https://xbrl.sec.gov/exch/2023/exch-2023.xsd#exch_XNYS"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_ExchangeDomain_d149a6ac-a919-4d6f-baf4-79b629d9ed65" xlink:to="loc_exch_XNYS_86ee216d-6142-4a59-a581-fcf4f4ba7574" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_e1e7a9ab-c4b4-458d-b998-09ea270ba3a7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_DocumentType_e1e7a9ab-c4b4-458d-b998-09ea270ba3a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_002d16ea-9e61-4b4b-96ad-df7caf929b57" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_DocumentPeriodEndDate_002d16ea-9e61-4b4b-96ad-df7caf929b57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_7f3e412b-bca8-48bb-a179-8c3c3837ef33" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_EntityRegistrantName_7f3e412b-bca8-48bb-a179-8c3c3837ef33" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_71ba1b02-d759-43db-a41d-815924fc4501" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_EntityAddressAddressLine1_71ba1b02-d759-43db-a41d-815924fc4501" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_87200833-9d9f-4c60-ad0c-82db1f536c26" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_EntityAddressCityOrTown_87200833-9d9f-4c60-ad0c-82db1f536c26" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_7822e9eb-fb62-4964-861c-16c2b010ba6e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_EntityAddressStateOrProvince_7822e9eb-fb62-4964-861c-16c2b010ba6e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_bed2d1db-d912-400c-98ec-607dcc79dce2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_EntityAddressPostalZipCode_bed2d1db-d912-400c-98ec-607dcc79dce2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_597d0000-e945-4e27-b52b-08666a892003" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_CityAreaCode_597d0000-e945-4e27-b52b-08666a892003" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_62c697f0-83f4-49e8-9ebd-b7c81508373f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_LocalPhoneNumber_62c697f0-83f4-49e8-9ebd-b7c81508373f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_da21532c-007c-4034-9bc8-1e62ae955f48" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_Security12bTitle_da21532c-007c-4034-9bc8-1e62ae955f48" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_9ce73781-82c2-40a9-b91d-dabc2bfdbeba" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_TradingSymbol_9ce73781-82c2-40a9-b91d-dabc2bfdbeba" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_a4b5d2ee-f1a2-49b9-8c32-0670efa2472b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_SecurityExchangeName_a4b5d2ee-f1a2-49b9-8c32-0670efa2472b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_2d047b22-fe3f-4579-a79c-67d9d8b3e025" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_WrittenCommunications_2d047b22-fe3f-4579-a79c-67d9d8b3e025" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_e620c58b-03d5-488d-94ea-0cc9b55230b5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_SolicitingMaterial_e620c58b-03d5-488d-94ea-0cc9b55230b5" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_f873c323-76d2-4192-907b-b262d560205c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_PreCommencementTenderOffer_f873c323-76d2-4192-907b-b262d560205c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_47e0010b-6302-4d10-892d-bb7e4e886711" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_47e0010b-6302-4d10-892d-bb7e4e886711" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_8aa42139-b73d-4c74-98a1-00cc80250972" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_EntityEmergingGrowthCompany_8aa42139-b73d-4c74-98a1-00cc80250972" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_2c8a3dd7-8b6e-40d1-bdde-83231fcb9480" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_EntityCentralIndexKey_2c8a3dd7-8b6e-40d1-bdde-83231fcb9480" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_4867b67d-0522-42c1-9fe3-77c4a6dc599a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_AmendmentFlag_4867b67d-0522-42c1-9fe3-77c4a6dc599a" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_bd6644ce-adeb-459f-b1ce-d0a754749bfc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_EntityTaxIdentificationNumber_bd6644ce-adeb-459f-b1ce-d0a754749bfc" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_71d4118c-d752-4e73-a66d-14576f3d56b3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_EntityFileNumber_71d4118c-d752-4e73-a66d-14576f3d56b3" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_4c7c685f-3a0e-42c3-a8f6-6be0f178be79" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_EntityIncorporationStateCountryCode_4c7c685f-3a0e-42c3-a8f6-6be0f178be79" xlink:type="arc" order="21"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>med-20241030_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:ff861412-6b9b-443a-a223-d13ffb79620b,g:78c4c6f0-d32f-420b-85de-ae2630e47498-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_ExchangeDomain_8b7f6a5c-4bee-4c34-bd37-bffd1d84894d_terseLabel_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:label id="lab_dei_ExchangeDomain_label_en-US" xlink:label="lab_dei_ExchangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Exchange [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ExchangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ExchangeDomain" xlink:to="lab_dei_ExchangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_87223d3c-c8d4-4ac2-8677-c22a3d332f1b_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_aa71d80a-698b-498b-9843-ce3f89331ea5_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_63df0268-11b7-467e-b9bf-68aa434d34e5_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_ea8c726b-238b-4ac0-acee-958c74fc1748_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_8d77744b-e630-457a-8002-84361bad6e61_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_c679feee-3e3d-4ee5-8807-f35c99be17ea_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_12a9d4a8-89f0-4d9e-b21f-119d5041ddc1_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_exch_XNYS_cc74b11e-889d-4491-b101-9e8c504624e9_terseLabel_en-US" xlink:label="lab_exch_XNYS" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">NEW YORK STOCK EXCHANGE, INC.</link:label>
    <link:label id="lab_exch_XNYS_label_en-US" xlink:label="lab_exch_XNYS" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">NEW YORK STOCK EXCHANGE, INC. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS" xlink:href="https://xbrl.sec.gov/exch/2023/exch-2023.xsd#exch_XNYS"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_exch_XNYS" xlink:to="lab_exch_XNYS" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_f37864ca-12e1-46a1-80fd-0c63d44cfb5d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_190aa1df-bdfd-4df5-9a3b-4a668bb33b87_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_b4fb1b0e-f40e-42b7-aff6-e177dbc5954a_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_f791fffc-8968-4e91-8598-67bb71c29823_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_532ece6d-7cf5-4c15-beda-0d441650d02c_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_528f5e7f-9342-41a8-b050-06772cc11d20_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_fa847fb0-749c-4688-9e3f-2f4c57d17dd2_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_ea36ec4f-5de6-43fe-bcb1-a08ee7c01e09_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_78ad4435-f3ca-446c-8d51-7fa24e4fae11_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_f89ddb11-c2cb-465e-9b83-d7a238a2678d_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityListingsExchangeAxis_f4fafb43-c908-4190-9856-03ed279aa8f6_terseLabel_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:label id="lab_dei_EntityListingsExchangeAxis_label_en-US" xlink:label="lab_dei_EntityListingsExchangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Listings, Exchange [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityListingsExchangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityListingsExchangeAxis" xlink:to="lab_dei_EntityListingsExchangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_210df1df-c6cf-4bd2-9a69-687546f45152_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_5ca40f0c-23c5-4233-a7ad-a2652330d796_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_fabece5c-abab-4296-992b-149609a756c2_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_6e63957f-90ca-4773-a556-05fa41bf68dd_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_dad60b77-1c25-4a7c-b4c8-57301aaa1b73_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_bb922f51-05cb-468d-9cfb-efdd7bb898a6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_d4741afc-6b5c-4223-8534-dfaa0ea96350_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>med-20241030_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:ff861412-6b9b-443a-a223-d13ffb79620b,g:78c4c6f0-d32f-420b-85de-ae2630e47498-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.medifast1.com/role/Cover" xlink:type="simple" xlink:href="med-20241030.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.medifast1.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_2da93b2b-827f-4878-8861-86993d0d2ebf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_5dd3c136-6ce5-4b90-8a8f-3ad7ecdb1c7c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_2da93b2b-827f-4878-8861-86993d0d2ebf" xlink:to="loc_dei_EntitiesTable_5dd3c136-6ce5-4b90-8a8f-3ad7ecdb1c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityListingsExchangeAxis_1bdd7cde-ff3b-4dc8-8a7c-126ed56ebedb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityListingsExchangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_5dd3c136-6ce5-4b90-8a8f-3ad7ecdb1c7c" xlink:to="loc_dei_EntityListingsExchangeAxis_1bdd7cde-ff3b-4dc8-8a7c-126ed56ebedb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ExchangeDomain_d149a6ac-a919-4d6f-baf4-79b629d9ed65" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ExchangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityListingsExchangeAxis_1bdd7cde-ff3b-4dc8-8a7c-126ed56ebedb" xlink:to="loc_dei_ExchangeDomain_d149a6ac-a919-4d6f-baf4-79b629d9ed65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_exch_XNYS_86ee216d-6142-4a59-a581-fcf4f4ba7574" xlink:href="https://xbrl.sec.gov/exch/2023/exch-2023.xsd#exch_XNYS"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_ExchangeDomain_d149a6ac-a919-4d6f-baf4-79b629d9ed65" xlink:to="loc_exch_XNYS_86ee216d-6142-4a59-a581-fcf4f4ba7574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_5dd3c136-6ce5-4b90-8a8f-3ad7ecdb1c7c" xlink:to="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_e1e7a9ab-c4b4-458d-b998-09ea270ba3a7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_DocumentType_e1e7a9ab-c4b4-458d-b998-09ea270ba3a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_002d16ea-9e61-4b4b-96ad-df7caf929b57" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_DocumentPeriodEndDate_002d16ea-9e61-4b4b-96ad-df7caf929b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_7f3e412b-bca8-48bb-a179-8c3c3837ef33" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_EntityRegistrantName_7f3e412b-bca8-48bb-a179-8c3c3837ef33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_71ba1b02-d759-43db-a41d-815924fc4501" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_EntityAddressAddressLine1_71ba1b02-d759-43db-a41d-815924fc4501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_87200833-9d9f-4c60-ad0c-82db1f536c26" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_EntityAddressCityOrTown_87200833-9d9f-4c60-ad0c-82db1f536c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_7822e9eb-fb62-4964-861c-16c2b010ba6e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_EntityAddressStateOrProvince_7822e9eb-fb62-4964-861c-16c2b010ba6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_bed2d1db-d912-400c-98ec-607dcc79dce2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_EntityAddressPostalZipCode_bed2d1db-d912-400c-98ec-607dcc79dce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_597d0000-e945-4e27-b52b-08666a892003" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_CityAreaCode_597d0000-e945-4e27-b52b-08666a892003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_62c697f0-83f4-49e8-9ebd-b7c81508373f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_LocalPhoneNumber_62c697f0-83f4-49e8-9ebd-b7c81508373f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_da21532c-007c-4034-9bc8-1e62ae955f48" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_Security12bTitle_da21532c-007c-4034-9bc8-1e62ae955f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_9ce73781-82c2-40a9-b91d-dabc2bfdbeba" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_TradingSymbol_9ce73781-82c2-40a9-b91d-dabc2bfdbeba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_a4b5d2ee-f1a2-49b9-8c32-0670efa2472b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_SecurityExchangeName_a4b5d2ee-f1a2-49b9-8c32-0670efa2472b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_2d047b22-fe3f-4579-a79c-67d9d8b3e025" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_WrittenCommunications_2d047b22-fe3f-4579-a79c-67d9d8b3e025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_e620c58b-03d5-488d-94ea-0cc9b55230b5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_SolicitingMaterial_e620c58b-03d5-488d-94ea-0cc9b55230b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_f873c323-76d2-4192-907b-b262d560205c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_PreCommencementTenderOffer_f873c323-76d2-4192-907b-b262d560205c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_47e0010b-6302-4d10-892d-bb7e4e886711" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_47e0010b-6302-4d10-892d-bb7e4e886711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_8aa42139-b73d-4c74-98a1-00cc80250972" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_EntityEmergingGrowthCompany_8aa42139-b73d-4c74-98a1-00cc80250972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_2c8a3dd7-8b6e-40d1-bdde-83231fcb9480" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_EntityCentralIndexKey_2c8a3dd7-8b6e-40d1-bdde-83231fcb9480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_4867b67d-0522-42c1-9fe3-77c4a6dc599a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_AmendmentFlag_4867b67d-0522-42c1-9fe3-77c4a6dc599a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_bd6644ce-adeb-459f-b1ce-d0a754749bfc" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_EntityTaxIdentificationNumber_bd6644ce-adeb-459f-b1ce-d0a754749bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_71d4118c-d752-4e73-a66d-14576f3d56b3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_EntityFileNumber_71d4118c-d752-4e73-a66d-14576f3d56b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_4c7c685f-3a0e-42c3-a8f6-6be0f178be79" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_392a64d7-b21c-40a5-8148-079921b7227d" xlink:to="loc_dei_EntityIncorporationStateCountryCode_4c7c685f-3a0e-42c3-a8f6-6be0f178be79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>imagea.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 imagea.jpg
MB5!.1PT*&@H    -24A$4@   ,4   !%" 8   #ZB"(H     7-21T( KLX<
MZ0    1G04U!  "QCPO\804    )<$A9<P  %Q$  !<1 <HF\S\  #W(241!
M5'A>[;T'F)55EB[<5R5#D0SM=,]X9]J>Z7YL.XUV4MM68B6JR$DE2DZ5,Q6A
M@"*#!,DY!P$11#(H2A3).>=8^9Q35>]]W_6= T@[=^#^/__,_]RSBWV^M,/:
M:Z]WA?T%?@1_\B=_^E[R@\*?_.FAY >%/_G30\D/"G_RIX>2'Q3^Y$\/)3\H
M_,F?'DI^4/B3/SV4_*#P)W]Z*/VW $596=G?97_RI_^JY >%/_G30^DQ02%A
M?2A+@+^7O9<>2J7>[%PJ15FIQWO$?7A8M<2R7?W?@H+7[/H#VQ_,#^[];])_
M6L"?_F]+!,7WQ?7ODD^RF,O**+PFP!)H"3"SA+M$F?O*'K954L86N2^A+2WE
M?BF*6;J EPI<!$%),:O<06E)$;.; "E@U0(6=\'C868]CZJJ3]9S?D6CVF1?
MZO/!K8\69M&FOCW,;,G^2DM+F$D%LUIRVF2R9OES[X0_^=.C@.*!5%;F"+C^
MM.^X.KY]76=F4Z7\*2$,RDH)A=)"ELZG@+J03] 4,Y>X[Q $-U#HRD41A3+?
M[>)Y-XJX+2PN0C&W'@IR"06\C/4()>9\[A-$_*/H6Y:(*_O^M%]"(G1-T/#0
M\@@0924DBMFV&H<WVX\?%/[T4'I,4-S/DB5?EJYV?R^7,<L"2)L7L7P^!;40
MA1+^8L*CZ"X!D(M\5K[+\LIWM*65*?*XX7(7LH[+R08*V1E:%_;DM'V_+_7M
M&X'/7IB<,]\CD);+LEVP?Y8MW=OQ)W]RTF.!XIY@/9#E_[N5V8:;(NFR3%'6
M94FHAS]TE\I*"1,7A;K(@Z+"(EJ-,IP@&A9]<Q)3-N["WIOY!HP"@J*49<M*
M"0:Z.SZRM!&5<HN<3$O 3%M@U^YETF* ,(2PAMPYMS?KF-=\5D7%_,F?'DX/
M!-H2$0J-Y?] 7.CB6/P@:5=0[ V.!0<GNRS+2A &)H-6IY2N3QGC!@F\AR+-
M^M?<'L2-7X2?A47@IZ']$!HW"GLOWT8!)=IEP" HO&Z9FG$L@H3:L1Z"H2\[
M);Q9_IN (<!JUX#)1BS6<<K(P7*<,!W[DS]]/_WHOOC?!X6S$N1H8#=C !>%
MR4,)*Z$&]Y1)^ D!7G>QG.._*VM?1R44TQ)& *#H4@[YY^Q)>)T>=&;'F0OX
M;9M(U SJAX#@2#Q;OQ-&K=A@T4.!7"ZOL,L:R'$JY)Z+?3M2+@K8H_4O.@3%
M,A3S6& TAXO$%W+K(C@,6(IE"$@!X3X@E#5*97_R)R?]("A,E*GAW;0*A2X&
MO]3J.BMA*_)F>?G:2H@E?#J6&$NC:S^/6<#(9<6;C"-.7+F*DU=N6GF5V7;V
M*G[?,1/50A)0HUDR:C3LBH\^WVYMY9*6L[=NXO"E*SB?YW+B#6;UYXLAM/71
MXX3AJN?L^[8^V@H)",4S+H\LF<]*..#R619_\B=?^@%0.$NN6K61&U/H=N/2
MM1N8N609AL];C)&+5F#$HI48OOA3C%RV%B.6,B]>@U'*"U=AU((5&+U@)7)F
M+4'&N/E(&CD=75('HU54"EKT24+,X G8>O0<+K*G;I/7H4I(?U1NE(*_Q4_&
M[@(7CN85(V?&,K2-S$"S7NGHD#06D8-G(77T(@R=QK[GK,3(N>IG-6GYC'1\
M1CK68.A"7EOZ&7+8_S#2,73N8HR>.P^[CATC<,I01(![-"ZZ7SYWSZ E4-C8
M_<F?G/2#H) _K_L%+@)"5B*WJ B3YRY 2)=>".K:%V%]8M&P9RP:]$I PS[)
M".[7'Z&1J0B/3D.+A %HFS( [3,&H'?.6*1,G8^IVW;B\PM7L?'")61.FXN6
ML<E8>?0XIAZ\AMHMTE$I* ;]YFW#SH)B=!XP&EVSAF/UD=/8>/D&YN\[@NQ%
MGR!RY$?HDCD8[Z<,1HOX@6@<F8Z0?BD(ZIN$P-X)".P1A^"><0CE-HS;X$Z]
M$#]D&$Y<O89BNE#%=)W<'%,)0:$L4)B+9NZ8'Q3^=#_]("A*/$5TGUPH)BAT
M7R&/P,CCI6NN$IPM=.,879IC11X<II]TE.</4:X.L?H1UC[.?(+Y&/,A*N*M
M-UR8>^@,QGUS$-/V',>NVT7X]- 1=!W],>(_V867.@Q!]= XO#=Z!;J,F(OQ
MGW^)?06E6';T/";L.( 9^T]APY5\'*:O=-K;OMI6/NK=GF#?IRC?Q_,].)U/
M&O/+<"'/C;OLOY#TN1ADEW@44SB+ 8H\M'6 X0>%/WT__7!,03=#ED)W@!5D
M"QCY;BVU.O'"YGT'T"]K,-I$)Z%9=#*:QJ>C<6(&PI+2$40KT)"N4MU>_?&7
MSBEXI6TLG@_MAI\VC\3/6R7@M^U3D+WJ2RP\<0-A@^:@5G@\:H<EX ]=!V'"
MEH.8OOLTWHD9B9>:)S*GX,>!??!*BVC\M4,*ZG1+0;V^*0B-RT1X0A;"8M/0
M.#85S6.2T3(R'ET24C%_U3KDNA5T,]X@&$@VQU("C]M9%M:]DU+FDE*%[VXY
MBQPQ"QLC%)1[8PUE;Y#NRW;=UIE9AR=T2C<J%8,)7#K#*I9]Z8%=)SF5? U:
M<I8T>$K]^:YYK^O73GFWZLWV^>O\.<?*NG&IK2\Y38A>9^'Z@9%YRUDM9N>L
M,X;[5Y7L.30=6G9XI1+WDOKT9B>I/;FFVGH3Y<DYOM^NDH^'NJ(2UJYOD)9T
ME0>:$\O>4CSM]*?L%%?VG7'R@WO:/GIZ8$GVP72_$=^>!E!*@+B9;]'-6?O5
M+L0-'8^.:</1,CD'P?&#\ [C@#_WZ8_7NZ;@#YU2\3N"XK5>F13^&>@]>RM^
MV7XX*M2+1)6P6-0;- _#OCF-5WOD(" D%DD+=R)V[@;\I$T"?D3+4;Y1)IKD
MK$&7,9^B?L0P_*E#.E[OE,&V4_&7GAEX-R(;#6,&H4GR,+3M/Q0]LT?AXZ6?
MXOP=W24O-7I]#"X1$,H86= M+*'IT(WV$EH_389O^C1.6],2<'BVE-:RE&7<
M+BJ%8H*JA$ K9MBN&Y+>.A;D$R3NDB*Z9@54'AX4N-D&+WILJS4RE?4*C9<>
MM6O]JRYI<G&R[18005Q*ZUSFHOK1:I\4$L_10%M_4E NMB-[5ZQZ;%WM*VL<
M10(_KXM6-[6!5MOT1$%9:1&5F0?YO*8;IE)N);9>396@E3X]9H-"GJ>'4";%
M(::QJOKU$"HNGG.+)KK39<4HD-)D'VI?UE=C+2[2*%D$!<RWG2W[<]K*YP5%
M=J2)C990D6ALRFZV4\!^[K!<L3HD7S0@7O+.!?NEUP+R&.Y<DLQV;6SL3W2H
M!#N6$A0/M"IJ3S+H&NN[6;>4Q_=!^Y^G_P 4/Y0T0$XB&5%,BDFSK?)<85^[
M;A3ADR,7L/+,=2P[>Q-+3U_')Z>O8LF9BUATX2IF7<A'V)@UJ!B>A<K-<U"A
M>28%/P9_R9B'G_6:B,I-L_%6TC+4#$_',\T&H-S[X_%THQS\KL=$3-M]'9^>
MOXUE9VY@T:GK6,*VEYR\AI5GKV'%R8M8=^8JSI"76IV2%=.$NW1OQ%:5>$!F
MR%W2I.NFH*?8$7(Q\L2-.UBS^RC6[3V)PY?N<K)9EPPL$7C81HDQGTRF5+HY
M^0445JUH?7>>-.TZ@@T'S^(B738/^Y+UT>,IXHT$TF./JCB@<+2K)D9N'"=*
MSW?94K<'+O&4@JIZ+@D9:2SA=?5G[JL$G==EM94DS/8,%]O2R#3AVM.R=#%S
M(85 PN"A\$B RMB.!$A6LXCCRZ<5=5'0I7@%0E$GONB1&JH.LHV%>(U-<5SB
MAX2+"L)#_I444 D4D)-NMB&>%*.H.(^*@V 2H(W7ND\ED-$R&R@<X?9HH4/T
MBQ<\+_[HN3=7,>'*:\52+'H63J!A'8%%]+BMKE-'@JYXT.3/2!<?V"?W682'
MW">H!&!EC5M>@M'!_*CI,4"A3IU)TW-)!9Q :1XMO7YWY09Z#!Z)NMTBZ#8Q
MR(U.1Z.X 0B*R\#?X@;BY6X#4+[Y(#S=8C0JMQJ-@%;9J-2T/YX*2\,SK8:B
M7*L1J-AX$"HU&8SRK4;AF9;C4"5\&%YHE(Y?MD[!F[0*=1.'H7[B$-1C0%^O
M7R+>_K /6L:GXI.=>ZF7G.57:5&/:1K-N(\)I%EZDN9! N0B(PMY[3HGL<^P
M*?AY2 _\LG$$>N3,Q$4B2OJLV 3+J\V*.7D4+-53'UO.7,,[O3+P\R:]\:O&
MO3!^Z283'@F9AV!PW$T*/@7)S9.2.VE'W6.1N!1Q4HO(PSRZ<[(LN@_D-N$O
M(D\+6,;#,AX*-\NRGAY[<30K[0/I*J$ FB5A72*<X^2X9#4(I$)FNU=34LCR
MN<QY*'*Q+>H(%Z5&H), "K0<)OL6S^XK$QXZ/\P"GVQ';EF^"7FI)Y\:NM $
M7$ 6H//=I%EN*.F5; BLXH7N%4F@>8(TEQD8U8^RA-V$GG-46*2>5896@&!S
MT:)(?16S$0\99_>5U";+JVX^M[1[E#D]!4<:>4[DL@C+<8^TB2>E+I82GWA.
M<U)"'MN 'S$]EJ70X 4*38*V+DY2+B<WCYT?OG8=:9.FHEOV<'3,&HFV::/0
M/&TD0E)'H^6$=?A]RBJ"( ?E@_NC:H-^J!X<A7)!\?A1HS14:#48%4*34"4H
M 55"DE$A,!G5&R;CU0ZC\=Z8M0C)FHS 5+:7,1(?9(Y$QP$C$#MZ$K[X]K#=
MGS"70+-!YI@ZX@R74B.*#>9L:+5)#&+.(],$Y!4'S^%?6\2A1F <*C6(PM^B
M1N,HO2,!W6T30<U$KI>Z'"9+"Y\GS]N-FHN*(;U1LW$\:M7KB:2/5YN%<=,"
M<0Y]W;-7AQPET>$[+S$0N'3LE3_6(Q#<^3PG87+***N-'YI*T[820C=;,M=$
M5K#(YD./R0A0%#6KZVNG0$"5B^>^H]IJQOJV^SC,HNG!)#ITSKG&MB5HQ9S_
M(@HK>2NAUB.:4DAJ48Z.K(P$7@*K^F0@E06M(7=U70I +B6KWZ/+GGOC>1-R
M9O57)/-"<)<1W 9^)HU%933?VOJRC]<J]2"O7 1K(4'L6!I>_2%&_@?ID4$A
M$=,=9#D$)42VAQ,B?]3-;2$UAHB3.W6=G1\O<&'#V?/X_/PEK+UT#4DKOL0_
M4 #_I6TR6@^:A?YS/D/J@B_0=OA\_,_V0U M/ T-$J<B?NHJ9"_:@CX?+6.0
MGHT7@_JBQ:CEF'?Z&MNYC0VGSV#OM5NXS#YT0\^$C(/W2"CHZ^J1]#)J2TV$
M- RGCR4<']DTN5DV%TYS$MH,FHG*#9)0M?D(/!.6B5>Z#\<W5R68G <*G..R
MR!P7$W#4ZCP_?=L!5&\2C?_1- U56@U"M<!H)$W]PB;*11>K@(*R>?\13-^P
M'5.W?(,96W=CYF;F+;LQG?M3M^[!U.U[,6'#;DS;N!.+M^_"^;L4.=)SEPIG
M_<$CF++A2TS<O =3MNVU.K.8I[.-V=OV8"E=O9T7;^,294;"0ZAS3-PKS2>=
M=&,X=CUU+&$YQG*+UG^#61N^IIMW#+<Y!A?YY&9L=>C\6<S^8@MF;-F%C]G^
MQ&W<;MF)63R>R[YF,4_5^>T[>7X[OCYSCF,C/YB).WBH^A5?7F4>N7H#!B[\
M!%<(&"7BP(14G&<%[CB6K(SS0Y_&^"L@?$.7>,*Z78B:_ EZCIF+1,[]Y(V[
M\>6YR[C)^75D6!:T&-OV'<7L=1P+Z9Q,OD[;N@N3R-.)V_?@XVV[;0R3F*=M
MW8D9F[_"BIW?XG*QFV,6/SB7 MB3<)_4I%8W#!X:+ <J#47UP4'+Z%$#\*H$
M]0:%8^**SQ 6F8(_MH_ RZ'MT"@F$Y\>/(DKO"[P2,-<8'Y_U!S\N$E??'5+
MT^S4%]/V7,]%Q,<K\6(PW12"*;!;,E+'3,%WYRXYVH19IKR$P(0%T7JREK20
M[;((>AS%CJDA]72(+&LQZ9;IG4YFOL#@/J#I6#S3?"R>;C:$X!R M8R+;(0"
M/8$E?]YN8/+LL8)2!":.QU,A\2C79B0JM,A!I8912)ZYWNB5[CW)&*5!EUC4
M?*<M:@;U0 !I5ZX>V!.U0OJB6L,^J-HP$L\VBD6-^MWQDWH?8-KZ+VT\AV[E
MH6[W_JC\3B=4#HQ"M9 H!#3LA1H->Z!&4&]4"X[ \\T2\-ON0_ >73T)Q5E*
MG@'2.U8MH\O-N,N</6T-7OQ+:[SPMW:H3]Z=N"-GJ QW62=F^"0\^]>6>"Z0
M[2H']60?W9E[H5;#?J@5&('J01'LLP>JU6V+'B-GX@;;M!4] H&XL_39=V?P
M0F@7U [L@(4[#CHG"7"+/>51D"Y?+.*A19.:NDRS.GCV1ORQ0S;[ZDT>=D75
MP!ZH5*\7O8,^^$W'-/09NQA;CU\TOI[)+T2##^/P?)WV>([T! 1V)F][DC[R
M,X1TAD88CVL$]T+MX.ZH^6X[_*YU!+8SOI4B*Z:U?Z(QA9JUMN7$2<JH!2QK
MGU<E&-J3P%XI+,:<+W;@C9:]$=@I!@>NW#0BI>&_N9:'>7L.X\O;A>@W8Q7^
M[;U8K#]_$^OV'\2F8PYP5.X,&^N<-0'_6J\#TL<LQ/D;^70-* @TX19\:0+D
MLPBD!DMG=4;]2R<94*C!I:1D027<I^AK-NT_ALRE&]=L(N.9<2C7,L<$;M'7
M!UA330E@;N2S[=LNM]$R:.F7J!D:BRK-!C$^8@S4=#"J!L<@:=9:NRX*]E^Z
MCC]W2K3[+M5:,#YJDH)R89&HR(FK1$&KW#"6 IC,G(#:%/J:?VV%84L^,R6Q
MZ](-_+YM(JJ&)++N4%1NG,']& I,7U0.B<8SH8ELKS\JAB6B1F@TA;$OV@^=
M3>619_45!TDY*>"6PNDW=BFJO=V9@A2)/W5*P_[K#))Y_A+YUV[ -%1O$($J
MM)!5FF:SS614I#M;D?U5H4M;-3"1VT14#HI"E;J=T2KU(USCY!:1M[*9>C(@
MGW/3;L ,UHM$I;!XM!^V +?EY)O;DT^KI-4X67'&.:X"QE %N,4VTJ>MQC_4
M[4- D$?D9[G@GJ@4VIMCC4- : H%/ ;/UNV.M]I'XU!>/@X6%..U]_J@9CTJ
M"RJ'JG1;*X12>3090#X-1$"S#%1IE&#\K1T>@YH-NN/GX;VPX>@5 [$>0#7/
MX8F!P@"A[ R>$FF ,,OA-5%R!^63%_!8(-A]\@8V[3EN$Z+C+XZ<P=O=,Q#P
MU@?H,>%31,[<B%<[9B!]\0;\+*@57FGR(08N^@P7V!8= ARY=!&;]AZW.,#<
M):^ E[@=W];LM$CAK@13?4CS*F MH982B306U'".C[QP]Q'\4W@D D(&H&*3
MT:C0>@PJ-,NFYNF'"6NVL@03421/6/&%!&S]Z9MXY?TT5&(\5+EI#BHW&XZJ
M%-RJ0=%(F+7:RHBVO5=OXH]=TE$Y+(W &867NH[ G^*&XXW((:@3.12!4:-0
MMP]SWS&HWR<'8?W2L>7(48ZR#/LO7L<;[5)0G:"HVB0;/^LP%&_TSL';O0;@
MK7XY>+5;-EYH'L?K?5&K42*>#4]'0/UH-(B;1+=/G"+9_"VDY;S!_7Y35Z 2
MK5'-L%C\L5LF]MTJ,,U[GGQZ;\@< BW>@/ULNQ'X=<1'>"-F)/X:,PQUHH:A
M;L0HU(D8C7<CAJ-.SS2,7[[>%B<4Q[@\=TW];#U\!;]HG8IR6C%L.@C_V"(-
MZX]<<<2C]"YCE]L$A9M\+T,A^2B+MG#W<?QS>"R>"\E@3)F&?WX_'>TG+T?<
MLFUHE;,(/VN5AMJT'L^^W1ZMXG-PLM"%<U1\D:,FHW[?+/R5M/TY;@)>Z34!
M59L.0)7FF:C1+ 6O]AB*MZ)'H5[<2+S;)Q,?9H_'<7H>6A5$,4<M.9" /&)Z
M+% (##Y3Y&0*)DVEO=UF("$1QCR:<6H*K9O;Z@9S/O-W-V^A;J\8O!36$6_T
MR,"@%1N1LF -_M@S%>,V[T!(;#I^U28:+S?NC47T"VETZ?(X(6 >9UWW +0*
MX_$PEK'5!0&2XBCW@0)!H\T_K=\+$EK6+")]6O\N,T <S?4@)&8\A2F&S!S$
M"<TD(!@;M,A&Y7J]D35OG0&+SA?!Y;KGXG6?\ E!$XNJX4-0I<DP5 C+II49
M0E#$(G[V.MQD&0%Q#ZWAGPF**HWZXT<A6>@\?2/VT6(>*BC"&6J\<WE%.'6G
M""=RBW&,VW.,O?*H3<DE'+]Z#6^VBT/M4&KKD 3TG;4)1UCO9&X!#C/NV'TG
M'ZN/74+LI,7X[7MIJ-$@%L\VR:)P)2 H;CS;=)FP:MP"18^/EZ)\P^X(:!R%
MU[NG8>\=!Q3G. _OT\)4#(I$^?!4_#EI.C;>+<9^TGFTD/3173E-.I5/YA?A
M;#[KN<E9%[4MM:Z6BF69$J=_;HLEY<F_BFW&H&+#9'09L=3<+):BJZT@EU9;
M\T:QN"R:QB\G'^-I#0;C7]X;@:F[3N$4S^LYN-,4GS5'+Z)=YCB$]TXGZ,Y0
M9AC,<VYONSWF_AW(+\9> F7\CI.TTM&T<LELJQ<FT,(?(/T'>?T8Z;TLZ\YX
MPDVW#26DUBP_"7O$]!B@4*-DC++ P FPQ\>UY9&].BJU;%OZY&5YCC])U>ZB
M1I>+,6;M1ORD84O$3EN);SF)UWANR**5>+-K% 4G#V<I.!]O.H@7ZG5%UYR)
M9+#,KU9,BAGHZ6E=,II9OK.TEMT+X"09&,U2>8A)>LYT(P12K784T87*HXC?
M8E_CU[+M!OU1,SR; I&,MX8LQLM])J&B5L#J]$&/T<L-"%I2).5&\URZ>?_8
M@H (87 =-@S/M?T(/VX_#N7#!J)J:#)B9FZR<<AE^_;23;SU80K=FU@\31<D
M8O8&NR;0:#U(OW(R!2 )ECU)K''P[/ZKU_'O=+TJ$13EZ7ZE+-MAM,@"R/I)
MH)5%TQ='+N*=WL/IAM$%:9Q%'SN*?%QO-!112:A,'\9C%1D?!-#=>+U;!O;>
MI@O#\^=)1ONA\U"%L4T W::Z\1-QG)TXUI4ZC5DSK:U99NZ)]B(*IH+X7"J9
MS>>OXQ?MT^C*T*5KGHT*K4:C2OA@NL%9V'3Z!MNBBJ(PV[T+BH1<6BV.M,B>
MP1B"KEG@8 3W7VB/Z%QC#[=)F2R)Z+M(RW+L9B%N4IOF4O&Y*$-*<@@T?LWC
M_+VG4)/N9Y4FZ7B^43\LY+'J.DNUSMSE4U'K9J#NJU%]4QZ>""C$)NE1'R@4
MS$HS24?SV(12UD)"*JB0-13(4@DNJVI B=.7XZ7@#S%MRY%[DS!NP2<(Z16-
M4[DW;. [KQ3@E\V2Z%YD,+:0[J<F)<B*B'JS ;04LDX"@];%M6QJI/EFDX&@
M_"NM'(G:(@*K@*T<+RQ%<-PT!I.#* P#\2*U[>C#%_!6^BRZ$O2IZT6B<?IT
MTU@26$W283K.#1-&,^",0G5JY5K-AZ+;@H/X9>_)J-1X(+5M/&)G;3:AE^#N
MNWP3;W:A%I>O3"L2-7N]:4&-O<BF2JMTM X<E_JX*PM&FB7XNZ[=P*]9]YGP
M)#PM4"S=[G7+R 'R5/>)M00JOJFO3PZ>I[9E7-0\@T"*QU][9N/HS;M4"LXK
MOGTFKL8S#:(1$)Z"/W0;B&^]H+A ]K0;O !5.-X:K!>:,(Y60;/)>336<2Z9
M]38EU0_K4!EQ/O/<;EL5.J>V9WR*"G3- JBI:[<=BHK-<NB*#J;6CD+:_,\-
MG':?Q\6L^P2D_2K/=1@Q'Y5)4_6P ?A5I\'X_/1EKQ#GH8 *K(#RE$N%ET</
M(Y>6*=\E:Z_XD=-+VO2&OL:_Y-L3!@JYF<^1UTMVG;2YUD**B]Z#W'?=EU&0
M;6,BW4\(%$IJ^#]K7!0XX%#@:[?<^2=&#2+#?L*@>>CR[5Y! 28M^11->L?@
M3-X=F^PU!R[CI: (A">.,D;JUIL$70,40\1$W1@2% V W/>1]"!E$HYB D?K
M]@+;QVOWH'9P$C5:#DUO K765.RE!6LT>!;]]%@$4(C?C!Z+7;F%IFDE0&/7
M[T5U!G!5&R5;4!T^;#&67RG%KQDK5 E-93 :B<19ZTS 1=O.:[?P!PIGE;!4
M/,5@NM^L#;9H(-#X+(,TG8[ESDGSZF861V"NUV^[9*!B.#4I ^L!BS9;'2D.
M\4#V1&Z)N*IV+C%WG;@4E<(9(#=/I]L5C?G;G!4@7>\W^3/\J $#];!TQA0#
M<8!NF("NF*+=T,4,IF-1O5$<&L:-QGFQF-=\60*F\:B\M+Y6^62M-6?;;[KQ
M^]Y#&:MH$2 "S4:OQ=M9R_%,HR148ESVQH?IC(]NVUSHYIL>LRBDL*J]H4LW
MVXI30)-D\B@2;T5E8_G>P[C.:Z)98RURY=,J,9R7,J5RD_NMFW^Z\:H2^EU$
MRU KI)]9BNJ-XK%XSRFG/]'*K965B?H_3(\)BD=+/@+M.1VZ,G)I)+ZK]AS#
M2_7:HEY/!ICG&(CQW-A/MZ%I\@C3J#+M/8?,Q L,PK/FKK%),9>,H)"U$8CD
MVGCUFF6;1G7XO:3;_]0JU#3%I.'H]5S4[3D(5>GW5J:9_Z?6R5AZ^#3.L&2G
M2:OI&L63N0S8/AR K5=NF(;>30'_8X]L5 M)0@U>^Z<6"9AUZ"(VYY;AU<Y#
M4:U1*MV7""3-^MPF5)/^S8U;>(UU*O-:Q<89^$O";$3.VHKXF>L1/W4U$F:N
M0_2,-8B=NA+C/]V,B\4>:D:OE:'KI6>[K+^@& Q>L,6 H[4$8L?&8Y:1YV1=
M!-Q%WYU [<:]4*49P<2@.VK\,N.1P-3OXU5XNB[=OK!,LQ0"A6B\Q+KO#UF
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M#_UY"GZ %Q32H&8I!(KN#BBT)%NEZ2!;L:I% 7PV,!JU!3Y:G&IU/L0?/HC
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MPBC(H5$8L'B3N4$:L:(B*0(MMRJNT).B&N47Q\_C?]*M"Z!+6"4P'1U'+;5
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M?,.80J (("@J4%/&4MMKLD63^A+U!DKOL>C7BT;2?GNN7,-K71,8BT0QP(]
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FR0\*?_*GAY(?%/[D3]]+P/\"T78;DKZ")#(     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45689906445760">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Nov. 04, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct. 30,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MEDIFAST, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">100 International Drive<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Baltimore<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">21202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">410<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">581-8042<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MED<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000910329<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">13-3714405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-31573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityListingsExchangeAxis=exch_XNYS', window );">NEW YORK STOCK EXCHANGE, INC.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityListingsExchangeAxis=exch_XNYS">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityListingsExchangeAxis=exch_XNYS</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M9</GBMH=YPI;S%9N[^!F/8*A#/+AO W9IG;UB@LT)<FI_-[!K;I(TI*]D&D
M1&)=. 3B_@V2M'/>N:2N:W<QPJ.E/^[:!>&M"+$9J4$$_/V\0[N7'0RI\G8'
MM^9R.^)+E4B5Y^MHF>/)#$KN]>14WJ ^GF"0E>\[N%W/)D_DZ\/C'5DL'[P[
M,OG#^SR:?9K4K94++%3O.[=,3C4I.-W_?8^'3A#?2UQ-&PYN\V]+$3)Y\;<L
MWO"3VY@&H=G71>V8MX\V[N8ER#TS)IN2D*]!QVY=0O_5X;W"H:%EDN_E5U)K
M&>6'6\Y@IC WP/6UE/JM85X/E&]WAO\ 4$L#!!0    ( (&"9%F?H!OPL0(
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M3AI_YHOA/UY_ 5!+ 0(4 Q0    ( (&"9%D'04UB@0   +$    0
M      "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ @8)D68+"
M41+N    *P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL
M4$L! A0#%     @ @8)D69E<G",0!@  G"<  !,              ( !S $
M 'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " "!@F19P"YWTWT$  #I
M$0  &               @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
M4$L! A0#%     @ @8)D69^@&_"Q @  X@P   T              ( !P P
M 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " "!@F19EXJ[',     3 @  "P
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52P4&      D "0 ^ @  %!0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="med-20241030.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.medifast1.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="med-20241030.htm">med-20241030.htm</File>
    <File>med-20241030.xsd</File>
    <File>med-20241030_def.xml</File>
    <File>med-20241030_lab.xml</File>
    <File>med-20241030_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "med-20241030.htm": {
   "nsprefix": "med",
   "nsuri": "http://www.medifast1.com/20241030",
   "dts": {
    "inline": {
     "local": [
      "med-20241030.htm"
     ]
    },
    "schema": {
     "local": [
      "med-20241030.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "med-20241030_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "med-20241030_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "med-20241030_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 28,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.medifast1.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "med-20241030.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "med-20241030.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitiesTable",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entities [Table]",
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Information [Line Items]",
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Listings, Exchange [Axis]",
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange [Domain]",
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "exch_XNYS": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/exch/2023",
     "localname": "XNYS",
     "presentation": [
      "http://www.medifast1.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NEW YORK STOCK EXCHANGE, INC.",
        "label": "NEW YORK STOCK EXCHANGE, INC. [Member]"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001628280-24-045012-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-24-045012-xbrl.zip
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MR%W;L<-0+^>#OJ/ZRX_HPBM)/YDR*NA@?W7=/;L(N*B*?LYXAQ_7%_<F=E
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M\NU@SP1R$\^==PKW:NT %@'U,:$,]%-,&EW?#4X1O!\38#WN=(Q2&*QQF"6
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MI6D4K?JJ:3"RC3UJX\"TB6+M_XKG8[]+3KEYGQPI5RWN)-MXYC:./12&GY3
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M5'1?:*H8O::AU)L5">P] KC; +=VS\YB97Q*E6ZC$@QO%XJ'8:'+:%GA4-)
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MQ6/OX_\!4$L! A0#%     @ @8)D6>%D9?H5$0  XG   !
M ( !     &UE9"TR,#(T,3 S,"YH=&U02P$"% ,4    " "!@F19D0T.8W<"
M  !M"   $               @ %#$0  ;65D+3(P,C0Q,#,P+GAS9%!+ 0(4
M Q0    ( (&"9%G]^WU'"P@  (<Y   4              "  >@3  !M960M
M,C R-#$P,S!?9&5F+GAM;%!+ 0(4 Q0    ( (&"9%G$ 9FDZ@L  .UD   4
M              "  24<  !M960M,C R-#$P,S!?;&%B+GAM;%!+ 0(4 Q0
M   ( (&"9%FF @;NN <   \\   4              "  4$H  !M960M,C R
M-#$P,S!?<')E+GAM;%!+ 0(4 Q0    ( (&"9%D8VE'80BP  $J^ @ >
M          "  2LP  !M961F:6YA;&5A<FYI;F=S<F5L96%S93$Q,"YH=&U0
52P4&      8 !@". 0  J5P

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>med-20241030_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:exch="http://xbrl.sec.gov/exch/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="med-20241030.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
        </entity>
        <period>
            <startDate>2024-11-04</startDate>
            <endDate>2024-11-04</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000910329</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityListingsExchangeAxis">exch:XNYS</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-11-04</startDate>
            <endDate>2024-11-04</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-21">0000910329</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2024-10-30</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">MEDIFAST, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-31573</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">13-3714405</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">100 International Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Baltimore</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">21202</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">410</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">581-8042</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-13">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-14">MED</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-2" id="f-15">NYSE</dei:SecurityExchangeName>
    <dei:WrittenCommunications contextRef="c-1" id="f-16">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-17">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-18">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-19">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
